Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters
Related Experiment Video
Updated: Aug 16, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
Howard Cuckle1, Peter Benn, Dave Wright
1University of Leeds, Leeds, UK. h.s.cuckle@leeds.ac.uk
Objective:
To predict the screening performance for 17 policies currently in use or being considered for the near future.
Methods:
Multivariate Gaussian modeling using parameters derived from published meta-analyses and new meta-analyses for gestation-specific nuchal translucency and between trimester correlations.
Results:
For a 1% to 5% false-positive rate, first trimester screening achieved detection rates up to 16% to 25% higher than the best second trimester combination. Screening in both trimesters sequentially could yield an even greater increase in detection of 24% to 35%. The most efficient sequential policy was contingent screening, which has a high detection rate with only 15% of women needing second trimester tests.
Conclusion:
Modeling with meta-analysis derived parameters provides a reliable guide for policy and favors a contingent screening policy. The widespread practice of calculating first and second trimester risks separately should be abandoned.

